Implementing Cancer Medicines on the WHO Model Lists of Essential Medicines Into National Systems

Key Points

• This viewpoint aims to explore how cancer medicines can be effectively adopted within national health systems from the WHO Essential Medicines List.
• Discusses the importance of integrating cancer medicines into national health systems
• Analyzes existing frameworks for implementation
• Reviews barriers to access and usage of essential cancer medicines
• Highlighting that many countries lack adequate cancer medicine availability
• Emphasizing the need for policy changes to facilitate access
• Identifying key stakeholders necessary for successful implementation